Association of ion transporters with CLD.
<div><p>Objective</p><p>The autosomal recessive disease congenital chloride diarrhea (CLD), caused by loss-of-function mutations in the <i>solute carrier family 26 member 3</i> (<i>SLC26A3</i>) gene, shows association with inflammatory bowel disease (I...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <div><p>Objective</p><p>The autosomal recessive disease congenital chloride diarrhea (CLD), caused by loss-of-function mutations in the <i>solute carrier family 26 member 3</i> (<i>SLC26A3</i>) gene, shows association with inflammatory bowel disease (IBD). However, it is unclear whether IBD risk is associated with genetic or immune signatures. SLC26A3 interacts with several ion transporters linked to intestinal inflammation, such as cystic fibrosis transmembrane conductance regulator (CFTR) and solute carrier family 9 member 3 (SLC9A3) causing congenital sodium diarrhea. We hypothesized that other epithelial channels affecting intestinal salt balance might modulate CLD phenotype or IBD risk.</p><p>Materials and methods</p><p>We analyzed 495 gene variants within 33 ion transporters among 28 patients with CLD and 44,443 population controls.</p><p>Results</p><p>We found three intronic variants at or near the <i>CFTR</i> locus (rs17132543, rs2283054 and rs76622533) showing statistically significant (<i>P</i> < 1.42x10<sup>-5</sup>) associations with CLD.</p><p>Conclusions</p><p>These data demonstrate enrichment of rare variants at the <i>CFTR</i> locus in chromosomes harboring the Finnish founder mutation for CLD.</p></div> |
|---|